Displaying drugs 11826 - 11850 of 12858 in total
N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide
Experimental
Matched Iupac: … (2S)-5-[(E)-(1-aminoethylidene)amino]-2-(phenylformamido)pentanamide …
[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID
Experimental
Matched Iupac: … 2-[4-(4-phenylpiperidin-1-yl)benzenesulfonamido]acetic acid …
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID
Experimental
Matched Iupac: … 4-({4-[(1E)-2-phenylethenyl]phenyl}carbamoyl)butanoic acid …
Spaglumic acid
Spaglumic acid is the β-aspartyl isoform of N-Acetyl-l-aspartylglutamate (isospaglumic Acid is N-(N-Acetyl-l-α-aspartyl)-l-glutamic acid). In eye drops, spaglumic acid is either a magnesium or sodium salt of N-Acetyl-l-aspartylglutamate. Spaglumic acid is a mast cell stabilizer. Thus it is used in allergic conditions such as allergic conjunctivitis. Specifically spaglumic acid is approved...
Experimental
Matched Iupac: … (2S)-2-[(3S)-3-carboxy-3-acetamidopropanamido]pentanedioic acid …
Glafenine
An anthranilic acid derivative with analgesic properties used for the relief of all types of pain. Glafenine is withdrawn from the American market.
Withdrawn
Matched Iupac: … 2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate …
Imidafenacin
Imidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. It is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical.
Investigational
Matched Iupac: … 4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide …
Chlorproethazine
Experimental
Matched Iupac: … [3-(2-chloro-10H-phenothiazin-10-yl)propyl]diethylamine …
Matched Categories: … Heterocyclic Compounds, 3-Ring …
Matched Categories: … Heterocyclic Compounds, 3-Ring …
Azintamide
Investigational
Matched Iupac: … 2-[(6-chloropyridazin-3-yl)sulfanyl]-N,N-diethylacetamide …
Cavosonstat
Cavosonstat is under investigation in clinical trial NCT02589236 (Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation).
Investigational
Matched Iupac: … 3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid …
Benzethidine
Experimental
Illicit
Matched Iupac: … ethyl 1-[2-(benzyloxy)ethyl]-4-phenylpiperidine-4-carboxylate …
Beta-D-Fructopyranose
Experimental
Matched Iupac: … (2S,3S,4R,5S)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol …
6-Carboxymethyluracil
Experimental
Matched Iupac: … 2-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)acetic acid …
alpha-Pyrrolidinononanophenone
Investigational
Matched Iupac: … 1-phenyl-2-(pyrrolidin-1-yl)nonan-1-one …
Cariporide
Investigational
Matched Iupac: … N-carbamimidoyl-3-methanesulfonyl-4-(propan-2-yl)benzamide …
Cutamesine
Investigational
Matched Iupac: … 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine …
Clobutinol
Clobutinol is a cough suppressant that is withdrawn from the US and EU markets. Clobutinol may prolong the QT interval. In 2007, Clobutinol was determined to cause cardiac arrhythmia in some patients.
Withdrawn
Matched Iupac: … 1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethylbutan-2-ol …
Methyl undecenoyl leucinate
Methyl undecenoyl leucinate is an active ingredient in whitening creams. It is an α-MSH antagonist that inhibits melanin synthesis and tyrosinase activity and reduces expression of various melanogenic genes.
Experimental
Matched Iupac: … methyl (2S)-4-methyl-2-(undec-10-enamido)pentanoate …
Displaying drugs 11826 - 11850 of 12858 in total